ASPI
ASP Isotopes Inc.
NASDAQ · Basic Materials · Chemicals · US
$2.06
−3.97%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$2.18
From 52W high−80.90%
Volume7.15M
Market cap$315.05M
P/E (TTM)—
P/S (TTM)10.2x
Div yield—
Key dataOct 19, 2026
Open
$2.18
From 52W high
−80.90%
Volume
7.15M
Market cap
$315.05M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.6x
P/E (TTM)
—
RSI (14)
25.2
MomentumView details →
1D Return
−3.97%
YTD Return
−62.90%
SummaryUpdated Jun 1, 2026
ASP Isotopes Inc. (NASDAQ:ASPI) is a pre-commercial stage advanced materials company founded in 2021 and based in Boca Raton, Florida. The company went public in November 2022 and specializes in the production, distribution, marketing, and sale of specialized isotopes for medical, energy, and industrial applications. ASP Isotopes operates multiple manufacturing facilities and has recently transitioned from development to early commercial production across several isotope product lines.
Similar companies
Latest newsMore news →
ENDRA Life Sciences amended its Agreement and Plan of Merger with ASP Isotopes, Noble Africa and Renergen, revising the minimum cash closing condition to $3,800,002.59 and increasing Renergen's borrowing capacity under the ASPI Term Loan Facility from $80 million to up to $200 million.18d agoASP Isotopes said the proposed phase 2 expansion of the Virginia Gas Project would be about 13 times the size of phase 1, with construction expected to start in the second half of 2026 and take about 44 months.40d agoASP Isotopes is seeking a further $750 million in senior debt from the US International Development Finance Corporation and Standard Bank South Africa for phase 2 of the Virginia Gas Project.40d ago